AdvaMed Commends Medtech Execs Named to White House Economic Task Force
WASHINGTON, D.C. – Several prominent medical technology company executives have been named to the White House task force designated by President Trump to provide recommendations on how best to safely reopen the U.S. economy in the wake of the coronavirus (COVID-19) pandemic.
“The inclusion of so many medtech community leaders on this key White House task force speaks to the important role our industry will play in getting America back to work,” said Scott Whitaker, AdvaMed president and CEO. “The medtech executives on this task force have decades of experience in getting crucial devices and diagnostics into the hands of those who need them, and the country will be well served by their expertise.”
Medical technology company executives on the White House task force include:
- Cardinal Health – Mike Kaufmann
- McKesson – Brian Tyler
- 3M – Mike Roman
- Abbott Laboratories – Robert Ford
- Johnson & Johnson – Alex Gorsky
- Thermo Fisher Scientific – Marc Casper
- Roche Diagnostics – Matthew Sause
# # #
AdvaMed member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. AdvaMed members range from the largest to the smallest medical technology innovators and companies. For more information, visit www.advamed.org.